Metabolomics Pathway Analysis Service
Metabolomics pathway analysis is a specialized approach within systems biology that focuses on mapping and interpreting metabolite profiles in the context of established biochemical pathways. The main purpose of Metabolomics Pathway Analysis is to bridge the gap between raw metabolomic data and meaningful biological insights. By integrating high-throughput analytical techniques—such as liquid chromatography-mass spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS)—with advanced bioinformatics algorithms, researchers gain deep insights into how small molecules interact and regulate key cellular processes. This involves identifying metabolic intermediates, quantifying their relative abundance, and correlating these measurements with known pathways, such as those cataloged in KEGG, Reactome, and HMDB. Through metabolomics pathway analysis, investigators can pinpoint dysregulated nodes in metabolic networks, unravel underlying disease mechanisms, and discover novel therapeutic targets or biomarkers.
Because metabolic changes often precede observable phenotypic shifts, metabolomics pathway analysis is particularly valuable for early disease detection, treatment monitoring, and personalized medicine initiatives. For instance, shifts in glycolysis or amino acid metabolism may signal oncogenic processes, while altered lipid profiles can reflect cardiovascular pathology. By highlighting these metabolic perturbations, metabolomics pathway analysis supports drug development, toxicology studies, and nutritional research, offering robust data for shaping clinical and translational outcomes. This approach excels in uncovering previously unrecognized metabolic pathways that converge on diseases, thereby fueling hypothesis-driven research and multi-omics integration.
Service at MtoZ Biolabs
Leveraging state-of-the-art mass spectrometry platforms, MtoZ Biolabs offers a Metabolomics Pathway Analysis Service that delivers high-resolution metabolite identification, rigorous data interpretation, and customizable reporting. We employ stringent quality control measures and innovative bioinformatics pipelines to ensure precision and reproducibility. Researchers receive comprehensive pathway annotations, network visualizations, and actionable insights, enabling them to unravel complex metabolic processes and design targeted follow-up experiments. Whether you seek biomarker discovery, mechanistic exploration, or precision medicine solutions, our Metabolomics Pathway Analysis Service stands ready to advance your scientific endeavors. Free project evaluation, welcome to learn more details!
Figure 1. Analysis Workflow of Metabolomics Pathway Analysis Service
Service Advantages
1. Advanced Analysis Platform: MtoZ Biolabs established an advanced Metabolomics Pathway Analysis Service platform, guaranteeing reliable, fast, and highly accurate analysis service.
2. Customized Analysis Solutions: MtoZ Biolabs offers tailored Metabolomics Pathway Analysis Service options to meet specific research needs, whether focusing on targeted pathways or conducting broad-spectrum metabolic network analyses.
3. Integrated Multi-Omics Capabilities: Our Metabolomics Pathway Analysis Service facilitates the integration of metabolomic data with other omics platforms, providing a holistic view of biological systems and enhancing the depth of pathway analysis.
4. One-Time-Charge: Our pricing is transparent, no hidden fees or additional costs.
5. High-Data-Quality: Deep data coverage with strict data quality control. AI-powered bioinformatics platform integrates all Metabolomics Pathway Analysis Service data, providing clients with a comprehensive data report.
Applications
1. Biomedical Research
Metabolomics pathway analysis elucidates disease mechanisms and identifies biomarkers in conditions such as cancer, diabetes, and neurological disorders, facilitating therapeutic target discovery.
2. Drug Development and Pharmacology
Metabolomics Pathway Analysis Service supports drug efficacy assessment and mechanism elucidation by identifying affected metabolic pathways, enhancing drug safety and effectiveness.
3. Environmental Science and Toxicology
Our service assesses pollutant impact on biological systems by identifying metabolic disruptions through metabolomics pathway analysis, supporting ecosystem health evaluations and toxicology studies.
4. Nutrition and Metabolism
Metabolomics pathway analysis studies dietary effects on metabolism, aiding in the development of optimized diets and nutritional interventions to improve health outcomes.
5. Agriculture and Plant Sciences
Enhances crop quality and stress resistance by analyzing plant metabolic responses with Metabolomics Pathway Analysis Service, supporting sustainable agricultural practices and crop improvement.
Case Study
Using Metabolomics Pathway Analysis for Prostate Cancer Therapeutic Development
Prostate cancer (PC) is the second most common tumor in males globally, with limited effective treatments and rising multidrug resistance necessitating the discovery of novel therapeutic agents. Utilizing Metabolomics Pathway Analysis, researchers evaluated seven synthesized 2,3-dihydroquinazolin-4(1H)-one analogues against PC3 and DU145 cell lines. The compounds exhibited significant cytotoxicity and inhibited cancer cell migration, adhesion, and invasion. Metabolomics pathway analysis revealed that compound C5 and C6 disrupted key metabolic pathways in DU145 cells, including energy production, redox homeostasis, amino acid and polyamine metabolism, and choline phospholipid metabolism. Figure 2 illustrates the affected pathways, highlighting upregulation and downregulation of critical metabolites such as glucose 6-phosphate and glutathione. This comprehensive analysis identified how C5 and C6 impairs cancer cell proliferation and progression, underscoring its potential as an anticancer agent. Metabolomics pathway analysis provided essential insights into the biochemical disruptions caused by dihydroquinazolin derivatives, facilitating the identification of new therapeutic targets and validating the compounds’ antiproliferative activities. This case study demonstrates the capability of Metabolomics Pathway Analysis Service to enhance drug discovery and mechanistic studies in oncology.
Figure 2. A Scheme Representation of the Different Intermediates Affected Pathways in DU145 Cells after Treatment with C5 and C6
Deliverables
1. Comprehensive Experimental Details
2. Materials, Instruments, and Methods
3. Total Ion Chromatogram & Quality Control Assessment (project-dependent)
4. Data Analysis, Preprocessing, and Estimation (project-dependent)
5. Bioinformatics Analysis
6. Raw Data Files
How to order?
